To clarify the underlying mechanisms of TREK-1, this study carried out in vivo and in vitro molecular biology assays, finding that the NF-κB signaling pathway played vital function in the effect of TREK-1 on A1-like astrocyte activation in MDD. The gene discussed is NFKB1; the disease is major depressive disorder.